Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

3 High-Yield Pharmaceutical Stocks
3 High-Yield Pharmaceutical Stocks
Pharmaceutical stocks are generally an outstanding place to look for sustainable sources of passive income. Even though most companies offer fairly modest yields due to the costly nature of....
3 High-Yield Pharmaceutical Stocks
3 High-Yield Pharmaceutical Stocks
Pharmaceutical stocks are generally an outstanding place to look for sustainable sources of passive income. Even though most companies offer fairly modest yields due to the costly nature of....
Why Marijuana Stocks Won't Pay a Dividend, Even if They're Profitable
Why Marijuana Stocks Won't Pay a Dividend, Even if They're Profitable
There aren't too many industries that can grow at 20%-plus a year over the next five years, but marijuana could be one of them. Cannabis research firm ArcView believes the legal North American pot....
Celgene Could Be the Best CAR-T Stock to Buy, Not Gilead Sciences
Celgene Could Be the Best CAR-T Stock to Buy, Not Gilead Sciences
Gilead Sciences' (NASDAQ: GILD) recently approved Yescarta could be a billion-dollar blockbuster cancer-cell therapy, but the company could face stiff competition from Celgene (NASDAQ:....
Celgene Could Be the Best CAR-T Stock to Buy, Not Gilead Sciences
Celgene Could Be the Best CAR-T Stock to Buy, Not Gilead Sciences
Gilead Sciences' (NASDAQ: GILD) recently approved Yescarta could be a billion-dollar blockbuster cancer-cell therapy, but the company could face stiff competition from Celgene (NASDAQ:....
Celgene Could Be the Best CAR-T Stock to Buy, Not Gilead Sciences
Celgene Could Be the Best CAR-T Stock to Buy, Not Gilead Sciences
Gilead Sciences' (NASDAQ: GILD) recently approved Yescarta could be a billion-dollar blockbuster cancer-cell therapy, but the company could face stiff competition from Celgene (NASDAQ:....
Why Agenus Inc. Stock Slumped Today
Why Agenus Inc. Stock Slumped Today
Shares of the cancer immunotherapy and vaccine company Agenus (NASDAQ: AGEN) fell by as much as 16.7% on nearly five times the average volume today, before ultimately ending the day down by only....
Why TransEnterix Stock Tanked Today
Why TransEnterix Stock Tanked Today
Shares of TransEnterix (NYSEMKT: TRXC), an early commercial-stage robotic surgery company, ended today's trading session down another 16.4%. The company's shares have now given back a healthy....
Why TransEnterix Stock Tanked Today
Why TransEnterix Stock Tanked Today
Shares of TransEnterix (NYSEMKT: TRXC), an early commercial-stage robotic surgery company, ended today's trading session down another 16.4%. The company's shares have now given back a healthy....
Why TransEnterix Stock Tanked Today
Why TransEnterix Stock Tanked Today
Shares of TransEnterix (NYSEMKT: TRXC), an early commercial-stage robotic surgery company, ended today's trading session down another 16.4%. The company's shares have now given back a healthy....
Abbott Laboratories Q3 2017 Earnings Conference Call Transcript (ABT)
Abbott Laboratories Q3 2017 Earnings Conference Call Transcript (ABT)
Abbott Laboratories (NYSE: ABT)Image source: The Motley Fool.Q3 2017 Earnings Conference CallOct. 18, 2017, 9:00 a.m. ET Continue readingSource: Fool.com

	 
BOIRON : Activity in the third quarter of 2017
BOIRON : Activity in the third quarter of 2017
ACTIVITY IN THE THIRD QUARTER OF 2017 (Unaudited data) CUMULATIVE ACTIVITY AS OF THE END OF SEPTEMBER 2017 in thousands of euros 2016 2017 Variation at current exchange....

	 
BOIRON : Activité du troisième trimestre 2017
BOIRON : Activité du troisième trimestre 2017
ACTIVITÉ DU TROISIÈME TRIMESTRE 2017 (Données non auditées) ACTIVITÉ CUMULÉE À FIN SEPTEMBRE 2017 en milliers d'euros 2016 2017 Var. taux courant 2017/2016 Var. taux constant....
Here's Why Corbus Pharmaceuticals Holdings Inc. Jumped Today
Here's Why Corbus Pharmaceuticals Holdings Inc. Jumped Today
In response to upbeat results released from a phase 2 clinical trial, shares of Corbus Pharmaceuticals (NASDAQ: CRBP), a clinical-stage biotech focused on inflammatory and fibrotic diseases,....
3 Reasons Cara Therapeutics Is a Better Growth Stock Than Novavax
3 Reasons Cara Therapeutics Is a Better Growth Stock Than Novavax
At one point this year, Cara Therapeutics (NASDAQ: CARA) stock was up more than 175%. Most of those gains were given up, though. The stock is now up a little over 30% year to date. But that's....
3 Small-Cap Biotech Stocks That Could Be Big Winners in 2018
3 Small-Cap Biotech Stocks That Could Be Big Winners in 2018
Small-cap biotech stocks, or companies with valuations ranging from $300 million to $2 billion, can generate truly astonishing returns on capital in exceptionally short periods of time. Several of....
3 High-Yield Stocks for Conservative Investors
3 High-Yield Stocks for Conservative Investors
Conservative equates to cautious. We're talking investing here, of course, and not politics. Conservative investors are by nature cautious. There's nothing wrong with that. After all, Warren....
3 High-Yield Stocks for Conservative Investors
3 High-Yield Stocks for Conservative Investors
Conservative equates to cautious. We're talking investing here, of course, and not politics. Conservative investors are by nature cautious. There's nothing wrong with that. After all, Warren....
3 Things to Expect in Illumina's Q3 Earnings Results
3 Things to Expect in Illumina's Q3 Earnings Results
A quick look at Illumina (NASDAQ: ILMN) stock's performance is all you need to know how the company's first two quarters in 2017 went. Illumina's share price has soared 60% so far this year after....
3 Things to Expect in Illumina's Q3 Earnings Results
3 Things to Expect in Illumina's Q3 Earnings Results
A quick look at Illumina (NASDAQ: ILMN) stock's performance is all you need to know how the company's first two quarters in 2017 went. Illumina's share price has soared 60% so far this year after....
3 Things to Expect in Illumina's Q3 Earnings Results
3 Things to Expect in Illumina's Q3 Earnings Results
A quick look at Illumina (NASDAQ: ILMN) stock's performance is all you need to know how the company's first two quarters in 2017 went. Illumina's share price has soared 60% so far this year after....
Why Spectrum Pharmaceuticals Stock Jumped Higher Today
Why Spectrum Pharmaceuticals Stock Jumped Higher Today
Spectrum Pharmaceuticals (NASDAQ: SPPI), a biotech developing treatments for various blood disorders and cancers, saw its shares gain as much as 51.7% today on over 19 times the average volume.....
Here's Why Ignyta Stock Soared as Much as 27.5% Today
Here's Why Ignyta Stock Soared as Much as 27.5% Today
Shares of pre-revenue biopharma Ignyta (NASDAQ: RXDX) jumped over 27% Wednesday morning after it announced promising interim results from an ongoing phase 2/3 clinical trial investigating the....
Here's Why Ignyta Stock Soared as Much as 27.5% Today
Here's Why Ignyta Stock Soared as Much as 27.5% Today
Shares of pre-revenue biopharma Ignyta (NASDAQ: RXDX) jumped over 27% Wednesday morning after it announced promising interim results from an ongoing phase 2/3 clinical trial investigating the....
Why Endocyte Is Rallying Today
Why Endocyte Is Rallying Today
Shares of Endocyte (NASDAQ: ECYT), a clinical-stage biotech focused on cancer, rose as much as 13% in early-morning trading on Tuesday on heavy volume. As of 11:35 p.m. EDT, the stock was up about....